Intralesional Vitamin D Injection for Treatment of Common Warts

• Status: Recruiting
• Trial end date: 2022-09-15
• Target enrollment: 0
• Participant gender: All

Summary

Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stephen P. Merry
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Adult patients seen at the Mayo Clinic Rochester practices

• Patients suffering from one or more cutaneous warts as diagnosed by the examining physician at baseline visit on typical diagnostic characteristics

• Able to provide consent

• Both recalcitrant and non-recalcitrant warts will be included

Exclusion Criteria:

• Patients with prior use of home or office-based destructive treatments for this wart(s) in the last 1 month with SA or cryotherapy

• Immunoadjuvant therapy for warts in the last 4 months (e.g Candida)

• History of vitamin D injection of warts ever

• High-dose vitamin D supplementation (>4,000 IU daily or equivalent) in the preceding 3 months

• Pregnancy or lactation

• Facial or genital warts

• Lesions not felt by the examining clinician to be a wart (e.g., corns or calluses)

• Immunosuppression (to include immunosuppressive medications or conditions as judged by the physician evaluating the patient at the baseline visit).